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Carotid graft replacement: A durable option
Henry C. Veldenz, MD, FACS, Rhea Kinser, RN, and George Neil Yates, MD, FACS, Elizabethtown, Ky
Background: Carotid artery bifurcation reconstruction after endarterectomy has been refined over the years. Methods
including primary closure, patch closure, and eversion endarterectomy have been proven to be durable. However, there
are patients who require more complicated reconstructions in primary or recurrent disease management. Carotid
replacement with a prosthetic interposition graft is potentially a durable option to reconstruct an artery that is technically
unsuitable for primary or patch closure.
Methods:The charts of all carotid endarterectomies (n 482) performed by the authors at our institution between January
1999 and December 2003 were retrospectively reviewed. Follow-up was performed in an Intersocietal Commission for
the Accreditation of Vascular Laboratories–accredited vascular laboratory. Patients were divided into two main groups:
carotid replacement with 6-mm expanded polytetrafluoroethylene (ePTFE) (REP) or standard endarterectomy (CEA)
with or without patch closure. The decision for REP vs CEA (as well as the type of closure) was at the discretion of the
surgeon according to an assessment of the end point, the distal internal carotid artery, and the quality and length of the
endarterectomy segment. Interposition grafting with a 6-mm stretch of ePTFE from the transected common carotid to
the transected internal carotid artery was performed in replacement reconstruction. The external carotid was ligated.
Follow-up statistical analyses were performed with the Fisher exact test and analysis of variance for nominal values and
t tests for continuous variables. Life table analyses were performed for patency and survival.
Results: Complete perioperative data were available for 478 of the 482 operations performed (including all REP cases)
during the study. At least one duplex ultrasound scan in follow-up was documented in 84% (n  402) of the patients. A
total of 51 were in the REP group, and 427 received CEA (95.3% with patch closure). Preoperative demographics,
preoperative symptoms, and degree of stenosis did not vary within the study groups. Three 30-day surgical deaths
occurred. The perioperative stroke rate between groups was not statistically different (REP, 1/51 [1.9%]; CEA, 3/427
[0.70%]; P .35). Long-term patency and stroke-free survival rates at 3 years exceeded 96% and did not vary significantly
between groups. The presence of a patch in the CEA group had no influence on outcomes. Duplex follow-up scan
averaged two studies for at least 14 months in each group. Significantly more REP cases were reoperative procedures.
Conclusions: Carotid interposition reconstruction with an ePTFE graft is an acceptable alternative in cases in which the
standard technique would be technically difficult or compromising to the endarterectomy closure. Carotid ePTFE
interposition graft replacement seems to be safe and durable and to have no increased perioperative risk or altered
intermediate-term outcomes. (J Vasc Surg 2005;42:220-6.)Carotid endarterectomy is currently widely accepted
and practiced for treatment of severe symptomatic and
asymptomatic carotid stenosis.1-3 Technical excellence
in the performance of carotid endarterectomy is a pre-
requisite for optimal results. There are many variables in
carotid surgery, including shunting, closure method,
type of anesthesia, hemostasis methods, and anticoagu-
lation protocols. Whatever combination a surgeon
chooses in performing a carotid endarterectomy, the
goal is a disease-free operative site with a technically
acceptable reconstruction, a low rate of recurrent steno-
sis, and satisfactory neurologic outcome.
Because surgeons strive for these goals in every patient,
there are situations in which different options might be
needed to achieve the desired result. Carotid atherosclero-
sis can extend further distally into the internal or proximally
into the common carotid than initially anticipated. The
remnant arterial wall can be less than optimal because of
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220either the plaque or an inadequate endarterectomy. A re-
operative endarterectomy site may not have enough quality
artery to close. Excess arterial length from tortuosity can
interfere with conventional closures. The use of direct
inline synthetic interposition grafting for the bifurcation is
one way to correct potential problems in achieving the
desired reconstruction. The trauma literature4 is supportive
of this approach. The purpose of this article is to review the
results of carotid interposition grafting and its use in the
treatment of selected patients with conventional carotid
atherosclerosis and recurrent stenosis.
MATERIALS AND METHODS
Four hundred eighty-two consecutive patients under-
going carotid reconstruction by the two senior authors
(G.N.Y. and H.C.V.) from January 1999 through Decem-
ber 2003 were retrospectively reviewed and grouped with
respect to the presence or absence of a carotid interposition
graft replacement (REP) vs standard endarterectomy tech-
niques (CEA). The institutional review board at the hospi-
tal where the procedures were performed approved this
study.
Patients were followed up in an Intersocietal Commis-
sion for the Accreditation of Vascular Laboratories–accred-
ited vascular laboratory with interval carotid duplex scans
and clinical examinations at 3 months and each year there-
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to 99%, and probable occlusion were used in this laboratory
for the period of the study, thus determining the 60%
threshold for recurrent stenosis. Digital subtraction an-
giography and, in more recent years, computed tomo-
graphic angiography were performed of the aortic arch and
carotid arteries when hemodynamically significant recur-
rent stenosis was identified. Antiplatelet therapy (aspirin
325 mg) was standard after surgery unless it was contrain-
dicated or other anticoagulation was mandated for coexist-
ing diseases. Clinical variables that were considered in-
cluded cardiovascular risk factors, preoperative stenosis and
symptoms, and procedural technical factors (Table I). Out-
comes assessed included death (both 30-day and long
term), neurologic complications, cranial nerve palsies, re-
current stenosis, and other postoperative events (Tables II
and III).
Patients were divided into two main groups: carotid
replacement with 6-mm expanded polytetrafluoroethylene
(ePTFE) (REP) or standard endarterectomy (CEA), with
or without patch closure. No vein graft interpositions were
used. The decision for REP vs CEA (as well as the type of
closure) was at the discretion of the surgeon, according to
an assessment of the end point, the distal internal carotid
artery, and the quality and length of the endarterectomy
segment. The specific reason or reasons for a replacement
were not tabulated because of the limitations inherent in a
retrospective chart review. Interposition grafting with a
6-mm stretch of standard wall ePTFE from the transected
common carotid to the transected internal carotid artery
was performed as an inline replacement reconstruction.
The graft ends were beveled to match the arterial segments.
Monofilament sutures were used with care to avoid any
purse-string effect. Shunting was selective, according to
carotid stump pressure and clinical presentations. The ex-
ternal carotid was ligated. General anesthesia was standard.
All patients received heparin and their anticoagulation was
routinely reversed with protamine unless contraindicated.
No patient required mandibular subluxation.
Follow-up statistical analyses were performed by using
the Fisher exact test and by using analysis of variance for
nominal values and t tests for continuous variables. Kaplan-
Meier life table analyses were performed for patency and
survival. In statistical analysis, the presence or absence of a
patch (used in 95.3%) in a primary CEA did not influence
outcomes, so all nongraft procedures were categorized as
one group for the analysis.
RESULTS
Patient historical preoperative data are summarized in
Table I. Complete perioperative data were available for 478
of the 482 operations performed (including all REP cases)
during the study. At least one duplex ultrasound scan in
follow-up was documented in 85% (n  402) of the pa-
tients by using the previously stated validated criteria and
the definition of 60% stenosis as a significant recurrence.
Preoperative demographics, preoperative symptoms, and
degree of stenosis did not vary within the study groups.Three surgical deaths occurred within 30 days (REP, 1/51
[1.9%]; CEA with patch closures, 2/427 [0.47%]; P 
.20). The perioperative stroke rate was not statistically
different between groups (REP, 1/51 [1.9%]; CEA,
3/427 [0.70%]; P .35). The combined stroke and death
rates were also similar (REP, 1/51 [1.9%]; CEA, 5/427
[1.2%]; not significant). All CEA patient morbidity and
mortality were in primary, nonredo carotid procedures.
The deaths in these patients were from myocardial infarc-
tions. The sole postoperative stroke patient in the replace-
ment group died in the postoperative period from a myo-
cardial infarction, and it is unknown whether that graft had
thrombosed. None of the few non–patch closure CEA
patients had a stroke or died.
Other perioperative outcomes are summarized in Table
II. Long-term patency and stroke-free survival rates at 2
years exceeded 96% and did not vary significantly between
groups, as noted in Table III and Figs 1 and 2. Because of
the smaller numbers, there was more than 10% SE in the
patients 3 years and later in the REP group survival. A
significantly higher proportion of reoperative procedures
occurred in the REP group. However, the presence of a
redo procedure was not significant in outcome differences
between the REP and CEA patients when this was sub-
jected to multivariate analysis. No hematomas occurred in
the REP patients, and only 5 of the 14 CEA patients with
hematomas required re-exploration. The other nine hema-
tomas were noted to be moderate, and no additional pa-
tient problems occurred from them.
DISCUSSION
Endarterectomy remains the standard with which all
other management of carotid bifurcation disease is com-
pared.1,2 Investigation of alternative methods, such as ca-
rotid stenting, is ongoing with the hope of having a durable
Table I. Demographics and clinical characteristics
Preoperative factor
Standard
CEA
(n  427)
Graft
replacement
(n  51) P value
Hypertension 71.7% 76.4% .49
Diabetes mellitus 30.7% 31.4% .93
Tobacco use 60.0% 72.5% .08
Asymptomatic 72.6% 78.4% .37
Significant coronary
artery disease history
52.2% 45.0% .34
Preoperative TIA 15.0% 9.8% .32
Preoperative stroke 12.4% 7.8% .35
Age 69.6 y 68.4 y .40
Side operated on: left 49.6% 54.9% .48
Sex (% male) 57.8% 52.9% .51
Redo carotid procedure 1.2% 56.8% .00001
Preoperative stenosis 81.3% 80.1% .42
Patch use in CEA 95.6% Not
applicable
Not
applicable
TIA, Transient ischemic event; CEA, Carotid Endarterectomy; REP, Inter-
position graft replacement.option with comparable results for the high-risk patient.5
ectom
positio
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have been extensively studied.6-8 The options include pri-
mary closure, patch grafting, and interpositional graft re-
placement. Factors influencing the choice include the size
of the artery, sex, reoperation, technical issues, and surgeon
preference.6-10
Saphenous vein grafting has proven to be a suitable
alternative for reconstruction. Treiman et al11 reported on
162 carotid reoperations, of which carotid resection with
autogenous vein graft replacement was used in 57 patients
with results comparable to those with repeat endarterec-
tomy. However, Rockman et al7 observed a higher rate of
late failures when a vein graft or patch was used as com-
pared with any synthetic material (26.7% vs 2.3%). The
saphenous vein is popular for harvesting for coronary artery
bypass grafting and peripheral vascular uses. Frequently,
the saphenous vein can be inadequate or has been previ-
ously removed in the management of vascular disease.
Synthetic material as a patch has been successfully used in
carotid reconstructions for many years with acceptable re-
stenosis and infection rates.7 Given the ease of use of
ePTFE, the lack of necessity for a separate harvest incision,
and the frequent lack of vein availability, we started using
ePTFE interposition graft reconstruction more readily in
difficult cases. In addition, the patients were not routinely
prepared for saphenous vein harvest. This factor, combined
with evolving comfort and experience with the REP tech-
nique, contributed to no vein graft use in this series.
Of the 51 interposition reconstructions in this series,
Table II. Perioperative complications and outcomes
Perioperative factor
St
Death—30 d 0
Stroke—30 d 0
Combined stroke and death—30 d 1
TIA—30 d 0
Cranial nerve injury—all 2
Cranial nerve injury—non–marginal mandibular 1
Cranial nerve injury—marginal mandibular 0
Infection 0
Hematoma 3
Myocardial infarction (nonfatal) 0
TIA, Transient ischemic event; NA, not applicable; CEA, Carotid Endarter
Table III. Long-term complications and outcomes
Follow-up factor S
Lost to follow-up 1
Duration of duplex follow-up scan 1
Average No. of duplex scans per patient in follow-up
Recurrent 60% stenosis
Late death
Late stroke
Late TIA
Late infection
TIA, Transient ischemic event; CEA, Carotid Endarterectomy; REP, Interthere were 22 (43.2%) primary operations and 29 (56.8%)reoperations. The primary interposition reconstructions
were used for difficult anatomy (kinks, coils, and so on),
unsatisfactory endarterectomized surfaces, and excessively
thin endarterectomized walls where it was believed that
standard patch graft closure would yield a compromised
result. In redo procedures, many arteries were believed to
be inadequate after the original patch closure was resected.
The exact indication(s) for patients could not be discerned
from the retrospective chart review process. In many pa-
tients, multiple reasons were probably important. Several of
the cases had heavy plaque longer than 7 cm, with extensive
common carotid and internal carotid involvement. Al-
though plication techniques are an excellent method for
dealing with anatomic lengthening and tortuosity, it was
not believed to be useful in cases in which the plaque
burden was also excessive. Again, evolving experience with
the replacement technique led to its increasing application
over the time of the series reported. Carotid stent angio-
plasty was not and is still not available at our institution;
therefore, no stent cases were included in this series. Pa-
tients were not referred away for carotid stenting if they
were believed to be at acceptable risk for either primary or
redo endarterectomy. One patient with extensive neck fi-
brosis from prior radiotherapy was referred for evaluation
for carotid stenting for a symptomatic stenosis.
Interposition graft reconstruction with synthetic mate-
rial has been shown to be a durable option in the trauma
setting.4 However, the use of synthetic graft replacement of
the carotid bulb has been limited. Sise et al12 reported on
rd CEA
427)
Graft replacement
(n  51) P value
(n  2) 1.9% (n  1) .20
(n  3) 1.9% (n  1) .35
n  5) 1.9% (n  1) .62
0.0% NA
n  12) 7.8% (n  4) .06
n  8) 1.9% (n  1) .97
(n  4) 5.9% (n  3) .0054
(n  1) 0.0% .44
n  14) 0.0% .19
(n  2) 0% .20
y; REP, Interposition graft replacement.
ard CEA Graft replacement P value
(n  61) 11.7% (n  6) .60
o 14.7 mo .78
2.2 .83
(n  11) 2.2% (n  1) .69
(n  7) 3.9% (n  2) .41
(n  3) 1.9% (n  1) .35
0.0% Not assessable
0.0% Not assessable
n graft replacement.anda
(n 
.47%
.70%
.2% (
.0%
.8% (
.9% (
.94%
.23%
.3% (
.47%tand
4.5%
5.2 m
2.1
3.3%
2.1%
0.7%
0.0%
0.0%26 ePTFE graft replacements in 23 patients, with 9 of these
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Volume 42, Number 2 Veldenz, Kinser, and Yates 223Fig 1. Patient survival life table. Data points end when the SE of Kaplan-Meier analysis exceeds 10%. CEA, Carotid
Endarterectomy. REP, Interposition graft replacement.Fig 2. Cumulative freedom from restenosis of 60%. Data points end when the SE of Kaplan-Meier analysis exceeds 10%.
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noted an overall restenosis rate of 20%, with a rate of 33%
(3/9) in the reoperative group. Our restenosis rate was
2.2% (1/45) in the REP group. The difference may be
related to the carotid reconstruction technique. Sise et al
preserved the carotid bulb with the proximal anastomosis
originating from the bulb, thus preserving the external
carotid artery and the carotid contour. Although Sise et al
did not mention the sites of restenosis, it may be that their
graft originated off of a bulb that was not normal because of
previous endarterectomy and that thus had a greater pro-
pensity for restenosis. In contrast, this series describes an
inline reconstruction with attention to anastomosing prox-
imally and distally beyond areas of disease or previous
endarterectomy. The external carotid artery was ligated. If
the artery was thickened with atherosclerosis at the proxi-
mal end, then focal endarterectomy of the common carotid
artery was performed. The single recurrent stenosis in our
series was in the distal common carotid artery just proximal
to the graft origin.
Cormier et al13 reported on 62 revascularizations with
ePTFE in the carotid position, with neurologic complica-
tions in 5% and early postoperative occlusion in 3.2%. Their
surgical technique involved long grafts from more proximal
inflow vessels. There were 48 grafts from the retroclavicular
common carotid artery, 9 from the subclavian artery, and 5
from the ascending aorta. The distal anastomosis was end
to side to the internal carotid artery in 54 and was end to
end in 8 cases. Although their series represents a longer
graft used for different indications, their favorable results
supported ePTFE as a reliable substitute. All of our grafts
were 6-mm ePTFE and were shorter (generally 4-8 cm)
than these long grafts. All were end-to-end anastomoses
proximally and distally, thus yielding an inline reconstruc-
tion with presumed less turbulent flow. These reconstruc-
tions were readily interrogated with cervical duplex scan-
ning. This method of reconstruction may account for the
low incidence of thrombosis (0%) and restenosis (2.2%;
mean follow-up, 14.7 months). However, no flow profile
analysis has been performed to support this concept, and
the mean follow-up is relatively short. Despite the relatively
short duration of duplex follow-up scanning, our patients
underwent more than 2 duplex scans on average in this
series (CEA, 2.1 examinations; REP, 2.2 examinations).
Certainly, continued duplex scanning follow-up is impor-
tant in all of our patients, but especially for the REP group,
to better understand the potential effect of neointimal
hyperplasia.
If shunting was necessary,14 then an Argyle shunt was
used through the graft and extracted through the proximal
anastomosis or a small graftotomy. No complications were
identified from ligation of the external carotid artery. Three
patients had bilateral carotid interposition reconstructions
with external carotid exclusion, without adverse sequelae.
There were no facial or neck symptoms, and there was no
jaw fatigue in any of these three bilaterally treated patients.
There are no data in our series about any effect of externalcarotid preservation. We did not identify any sequelae from
our routine ligation of the external carotid.
The interposition technique is straightforward to the
vascular surgeon. Interposition graft replacement results in
an acceptably low rate of perioperative complications (Ta-
ble II). The issue of cranial nerve injury was noted, with a
slightly higher rate of temporary marginal mandibular pal-
sies in the REP group. Multivariate analysis did not reveal
any significant effect of the presence or absence of a
reoperative procedure in the REP marginal mandibular
palsies. However, the marginal mandibular palsy is typi-
cally a retraction injury from the need for high exposure
and not from the carotid reconstruction per se. The REP
patients were typically selected because of extensive dis-
ease in the artery. These patients likely had more exten-
sive superior and inferior exposures. In this series, there
was a low rate of cervical hematoma and infection. There
was an acceptably low rate of recurrent stenosis in both
patient groups over the follow-up period. These patients
continue to be followed up with serial duplex examina-
tion as much as possible.
Some limitations of our study should be noted. The
apparent increase in either stroke or mortality rates alone
between REP and CEA patients is accounted for by the fact
that it was a single patient in the REP group who both had
a stroke and died from cardiac causes. The combined stroke
and death rates (CEA, 1.2%; REP, 1.9%) are numerically
similar and had no statistical differences. In addition, the
average duration of follow-up by duplex scan was only a
little longer than a year. Data past 4 or 5 years would be
desirable. Many potential indications for a replacement in a
redo carotid reconstruction are more intuitive to vascular
surgeons. This is especially so if bulky, recurrent disease has
to be resected. In a primary carotid procedure, it will be
useful to prospectively track indications for graft replace-
ments. Although these issues are important, the data pre-
sented still support the replacement procedure as an accept-
able technical option for the surgeon. The series presented
also seems to represent the largest patient volume with
carotid replacement to date.
CONCLUSIONS
Carotid endarterectomy is still a standard of care for
many patients with carotid atherosclerosis. Its success over
the years is the result of surgeons refining technical aspects
to improve patient outcomes. We still believe that conven-
tional endarterectomy with a high rate of patch closure is
the first approach to patients with severe carotid atheroscle-
rosis. However, patients exist in whom conventional end-
arterectomy closure may not leave the desired recon-
structed artery. Although this study has limitations,
primarily based on its retrospective design and short follow-
up, we believe that our data support interposition grafting
with ePTFE as a reasonable option for carotid reconstruc-
tion in patients with recurrent carotid stenosis or with
primary lesions not amenable to standard endarterectomy.
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Dr Bruce R. Perler (Baltimore, MD). I want to congratulate
Dr Veldenz and colleagues on an excellent series and thank them
for getting their very well-written manuscript to me in a timely
fashion.
In a sense, they’ve taken on a tough challenge, namely trying
to improve upon a great operation, carotid endarterectomy. I’m
not certain that they have achieved that goal, and that’s not
surprising.
In a series of 478 patients undergoing carotid endarterectomy,
they replaced the diseased segment with a PTFE graft in 51 cases,
or 11% of the patients. Although the differences were not statisti-
cally significant, bypass patients did experience roughly three times
the stroke, and four times the perioperative mortality rates of the
endarterectomy cases. This most likely reflects the more complex
disease in the bypass patients. On the other hand, perhaps it also
suggests that one should undertake this strategy very selectively. I
was frankly surprised by how often the authors have performed
these bypass procedures. I looked back over my experience of
roughly 1,000 carotid endarterectomies over the years, and 15
bypass procedures were performed, a rate of about 1.5%. I have
three questions for the authors:
1. I was hoping you could elaborate on the decision-making
process in performing a formal bypass procedure in these 51
patients. Was this decision made preoperatively in many cases,
for example is this now your routine for redo’s, or was it
necessitated primarily by unexpected technical difficulties at
operation?
2. You routinely ligated the external carotid artery, which can be
an important collateral source in some patients. Why not re-
anastomose the external carotid, since this adds very little to the
procedure?
3. Finally, you have concluded that this is a durable procedure, yet
your mean follow-up is only about 15 months. All of us are
aware that PTFE femoral-popliteal bypass grafts do very well for
2 years, and then patency falls off dramatically. Although you
have performed end-to-end anastomoses, are you concerned
that anastomotic neointimal hyperplasia will ultimately be a
problem in grafts to the internal carotid artery, since it is such a
small vessel?
I enjoyed this paper and thank the association for the privilegeDr Velendez. I would like to thank Dr Perler for his com-
ments. Certainly, there is a preoperative tendency in the redo
patient to do this. In addressing your question concerning where
there was three times the mortality and the increase in neurologic
morbidity, I would note that the combined stroke and death rates
were 1.2% in the control endarterectomies, while it was 1.9% in the
replacement patients. This is much less than a three-times-higher
rate for replacements compared to endarterectomy. The peripheral
nerve injury rate was a little bit higher, but again, that was more the
marginal mandibular involved in exposure. The decision making
intraoperatively in a primary case is when we do encounter much
more extensive disease and there are potentially some technical
issues with that endarterectomy. Certainly, I admit one of the
patients I ended up replacing was that patient I showed the CT
angiogram on where the artery was essentially not salvageable after
resection of all that heavy calcified plaque. In a redo situation, we
now are comfortable with the procedure and are leaning to the
replacement as our first approach.
With respect to ligation of the external carotid arteries, we
have seen no sequela with that, and certainly no patients with jaw
exercise pain or other adverse events from lack of that collateral. In
fact, there are three patients who over the years have actually had
both arteries replaced with this technique, and they seem to have
no sequela either on clinical exam from ligation of the externals.
Sometimes after resection of that bulb and/or interposition of the
graft, it is not as easy to make a good reimplantation of the external.
Since we have not found any problems, we just have basically come
to the conclusion to just ligate it.
And I have to agree with you that our follow-up is still an
average of 15 months. These patients at least have had two du-
plexes, but unlike the femoropopliteal population, where the rate
of graft recurrent stenosis is higher after 2 years, this is a much
shorter graft. It is a much higher flow situation and it certainly is a
different graft than a long piece of prosthetic in a femoropopliteal
position. Since we have reviewed the data and prepared the manu-
script, we have had more of the duplexes come through, and again,
another five patients have entered into 3 years of follow-up and
they actually have not had recurrent stenoses with this technique.
Certainly, it will require further study.
Dr Mark Friedell (Orlando, Fla). Henry, I think the impor-
tance of your paper is just to show that this is a good alternative for
those few times when you are in a tough situation. For me, I have
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where you have actually done the endarterectomy and you see what
you are left with looks worse than what you would have if you put
in a PTFE graft. I remember an occasion with one patient, there
was very thick plaque going all the way up the internal. There was
no apparent end point and my concern was tacking that plaque
down as best I could and just getting out of the situation I was in.
I put a graft in just like yours, and I have seen these people innone have restenosed. I think the importance for me of your paper
is that if you are in a situation where you are unsure of how to
proceed, that this is a viable alternative.
Dr Velendez. Thank you for your comments, Mark. We are
not trying to say you should do this instead of carotid endarterec-
tomy. We still believe conventional longitudinal endarterectomy
with patch closure is our preferred approached, but this has be-
come another tool if we are in a situation where we need to dofollow-up with duplex scans over the past 4 to 5 to 6 years, and something else.
